Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Zeiss Light and Electron Microscopy Combined in New Business Group

By Labmedica International staff writers
Posted on 28 Nov 2011
Print article
The Carl Zeiss Group (Gottingen, Germany) has launched a new microscopy business group that combines microimaging and nanotechnology systems. In the future, the company will be the world's only supplier to offer one-stop, innovative systems, and solutions for light and electron microscopy.

Customers are increasingly using both systems and want integrated software and workflow solutions. The combination of Carl Zeiss MicroImaging and Nanotechnology Systems into one business group fully reflects this trend.

"By fusing the two worlds of microscopy, we are opening up totally new perspectives to our customers in science and industry," says Dr. Ulrich Simon, head of Carl Zeiss Microscopy. "Carl Zeiss has been a pioneer in this field for more than 160 years. Carl Zeiss and Ernst Abbe together invented scientific microscopy more than 160 years ago. Since then, the company has constantly played a crucial role in shaping the progress of this technology. We are now opening an exciting new chapter in this success story."

The potential offered by combining light and electron microscopy is illustrated by Prof. Jeff Lichtman of Harvard University (Cambridge, MA, USA), who is pioneering brain mapping with light and electron microscopy by generating three-dimensional maps of the brain.

Competition is increasing all over the world: microscopy is a fast-growing market because it is increasingly developing into a basic technology that is now firmly established in many different fields. It is a market that is characterized by big providers and small specialists for specific technologies. The new Carl Zeiss Microscopy business group combines two strengths: it has the right size to carry clout and offers technological expertise covering the entire microscopy process.

Related Links:
Carl Zeiss Group
Harvard University



Print article

Channels

Clinical Chemistry

view channel

New Approach Improves Identification of Women at High Risk of Preeclampsia

A new meta-analysis examining 92 cohort studies involving over 25 million pregnancies has provided an unprecedented understanding of risk factors for preeclampsia—some risk factors being strong enough to warrant that a pregnant woman starts on prophylactic treatment with acetylsalicylic acid (ASA) when she has only one.... Read more

Genetic Tests

view channel

Patterns of MicroRNA Expression Distinguish Patients with Asthma and Allergic Rhinitis

Subsets of circulating micro RNAs (miRNAs) are uniquely expressed in asthmatic patients and in patients with allergic rhinitis (AR) and have potential for use as noninvasive biomarkers to diagnose and characterize these diseases. MicroRNAs are a class of about 20 nucleotides-long RNA fragments that block gene expression... Read more

Pathology

view channel

Liver Cancer May Be Diagnosed from Altered Sugar Metabolism

Altered gene expression that causes cancerous cells to metabolize fructose differently from healthy cells could be a significant new biomarker for diagnosing liver cancer. Dietary fructose is primarily metabolized in the liver and it has now been demonstrated that, compared with normal hepatocytes, hepatocellular carcinoma... Read more

Lab Tech.

view channel

Method Preserves Microfluidic Devices for HIV Monitoring in Developing Countries

Microfluidic devices with immunochemistry have broad applications in chemotherapy monitoring, transplant patient monitoring, and especially in monitoring the efficacy of antiretroviral therapy. Providing vital health care services to people in developing countries without reliable electricity, refrigeration and state-of-the-art... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.